Drug Shortage Report for MYLAN-GALANTAMINE ER
| Report ID | 191317 |
| Drug Identification Number | 02339439 |
| Brand name | MYLAN-GALANTAMINE ER |
| Common or Proper name | GALANTAMINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 BT, 100 BT |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-06-07 |
| Actual start date | 2023-05-29 |
| Estimated end date | 2023-07-28 |
| Actual end date | 2023-07-28 |
| Shortage status | Resolved |
| Updated date | 2023-08-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2023-08-01 | French | Compare |
| v17 | 2023-08-01 | English | Compare |
| v16 | 2023-07-25 | French | Compare |
| v15 | 2023-07-25 | English | Compare |
| v14 | 2023-07-18 | French | Compare |
| v13 | 2023-07-18 | English | Compare |
| v12 | 2023-06-13 | French | Compare |
| v11 | 2023-06-13 | English | Compare |
| v10 | 2023-05-31 | French | Compare |
| v9 | 2023-05-31 | English | Compare |
| v8 | 2023-05-31 | French | Compare |
| v7 | 2023-05-31 | English | Compare |
| v6 | 2023-05-16 | French | Compare |
| v5 | 2023-05-16 | English | Compare |
| v4 | 2023-05-08 | French | Compare |
| v3 | 2023-05-08 | English | Compare |
| v2 | 2023-05-01 | French | Compare |
| v1 | 2023-05-01 | English | Compare |
Showing 1 to 18 of 18